"... determine the antitumor activity, based on the objective response rate and median Progression Free Survival ("PFS")...".
In that case, the endpoint is met when half of the patients progress or die.
Is there not a possibility; albeit less likely, that there was a positive objective response rate? That is, some positive, significant change in the state of their disease or reduced median progression of that disease?
I find that the quote Dr. Sidor allowed to be attributed to her makes for uncomfortable reading: "We are pleased to have met the primary efficacy endpoint in the first stage of this study."
A positive objective response rate would certainly make Dr Sidor’s statement less uncomfortable, would it not?
I’m only trying to be hopeful here.